ICD-10 Coding for DCIS(C50.9C, D05.1, D05.1I)
Comprehensive guide on ICD-10 coding for Ductal Carcinoma In Situ (DCIS), including documentation requirements, common pitfalls, and billing considerations.
Complete code families applicable to DCIS
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| D05.1 | Intraductal carcinoma in situ of breast | Use for confirmed cases of DCIS with specified laterality. |
|
| D05.7 | Other specified intraductal carcinoma in situ | Use for DCIS cases with specific subtypes not classified under D05.1. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutDCIS
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting DCIS.
Omitting laterality in documentation
Impact
Clinical: Potential mismanagement of patient care., Regulatory: Non-compliance with coding standards., Financial: Loss of reimbursement due to unspecified coding.
Mitigation
Implement mandatory fields for laterality in EHR systems.
Coding DCIS as invasive cancer
Impact
Reimbursement: Potential overbilling if coded as invasive cancer., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate cancer registry data.
Mitigation
Ensure histological confirmation of in situ status before coding.
Unspecified coding
Impact
Use of unspecified codes when specific codes are applicable.
Mitigation
Ensure documentation supports the most specific code available.